EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 6-7 (Juin–Juillet 2013) Med Sci (Paris), 29 6-7 (2013) 577-579 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 6-7, Juin–Juillet 2013
Page(s) 577 - 579
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013296008
Published online 12 July 2013
  1. Jouet JP. La greffe de moelle osseuse, d’un siècle à l’autre. Med Sci (Paris) 2010 ; 26 : 447–448. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009 ; 373 : 1550–1561. [CrossRef] [PubMed] [Google Scholar]
  3. Yssel H, Bensussan A. Existe-t-il dans la peau une nouvelle population lymphocytaire Th22 distincte des lymphocytes Th17 ?. Med Sci (Paris) 2010 ; 26 : 12–14. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004 ; 21 : 241–254. [CrossRef] [PubMed] [Google Scholar]
  5. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011 ; 12 : 383–390. [CrossRef] [PubMed] [Google Scholar]
  6. Couturier M, Lamarthee B, Arbez J, et al. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect. Leukemia 2013 ; doi: 10.1038/leu.39. [Google Scholar]
  7. Hanash AM, Dudakov JA, Hua G, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 2012 ; 37 : 339–350. [CrossRef] [PubMed] [Google Scholar]
  8. Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin’ through a glass onion. Eur J Immun 2008 ; 38 : 3265–3268. [CrossRef] [Google Scholar]
  9. Dudakov JA, Hanash AM, Jenq RR, et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012 ; 336 : 91–95. [CrossRef] [PubMed] [Google Scholar]
  10. Williams L, Bosselut R. Interleukine 22–Une nouvelle piste vers la régénération thymique in vivo ?. Med Sci(Paris) 2013 ; 29 : 11–14. [Google Scholar]
  11. Dumoutier L, Lejeune D, Colau D, Renauld JC. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 2001 ; 166 : 7090–7095. [PubMed] [Google Scholar]
  12. Huber S, Gagliani N, Zenewicz LA, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012 ; 491 : 259–263. [CrossRef] [PubMed] [Google Scholar]
  13. Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012 ; 209 : 903–911. [CrossRef] [PubMed] [Google Scholar]
  14. Eriguchi Y, Takashima S, Oka H, et al.Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins. Blood 2012 ; 120 : 223–231. [CrossRef] [PubMed] [Google Scholar]
  15. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011 ; 331 : 337–341. [CrossRef] [PubMed] [Google Scholar]
  16. Bouladoux N, Hand TW, Naik S, Belkaid Y. Microbiote et lymphocytes T : les meilleurs ennemis. Med Sci (Paris) 2013 ; 29 : 349–352. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.